| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,691 |
3,268 |
$989K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
24,711 |
21,285 |
$931K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,722 |
12,547 |
$865K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,513 |
6,207 |
$303K |
| 80053 |
Comprehensive metabolic panel |
11,060 |
9,632 |
$117K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,080 |
11,332 |
$109K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,649 |
2,452 |
$103K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,593 |
5,825 |
$102K |
| 87400 |
|
16,633 |
7,025 |
$86K |
| 70450 |
Computed tomography, head or brain; without contrast material |
795 |
606 |
$54K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
301 |
151 |
$47K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
225 |
210 |
$44K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
250 |
227 |
$42K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,400 |
2,918 |
$35K |
| J1750 |
Injection, iron dextran, 50 mg |
160 |
150 |
$32K |
| 87081 |
|
2,968 |
2,833 |
$31K |
| 81001 |
|
7,361 |
6,395 |
$28K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
161 |
72 |
$25K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
508 |
416 |
$21K |
| 70544 |
|
75 |
66 |
$20K |
| 86756 |
|
876 |
836 |
$19K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
504 |
375 |
$18K |
| 81025 |
|
4,044 |
3,689 |
$14K |
| 87088 |
|
1,414 |
1,243 |
$13K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
188 |
180 |
$11K |
| 84484 |
|
1,188 |
822 |
$9K |
| 83690 |
|
1,327 |
1,203 |
$9K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
36 |
25 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
956 |
910 |
$8K |
| 0001A |
|
200 |
199 |
$7K |
| 0002A |
|
171 |
168 |
$6K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
589 |
218 |
$5K |
| 82150 |
|
635 |
589 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,693 |
3,286 |
$4K |
| 97597 |
|
264 |
101 |
$4K |
| 59025 |
Fetal non-stress test |
767 |
552 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,281 |
179 |
$3K |
| 81003 |
|
1,017 |
893 |
$3K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
20 |
14 |
$3K |
| 72141 |
|
13 |
12 |
$2K |
| 80076 |
|
288 |
275 |
$2K |
| 87106 |
|
208 |
189 |
$2K |
| 83735 |
|
176 |
170 |
$1K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
429 |
169 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,578 |
4,142 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
805 |
754 |
$1K |
| 0003A |
|
29 |
29 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,472 |
2,074 |
$587.11 |
| 82550 |
|
174 |
99 |
$528.00 |
| 82553 |
|
70 |
62 |
$527.31 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,288 |
6,258 |
$525.81 |
| 86140 |
|
192 |
180 |
$375.16 |
| 71046 |
Radiologic examination, chest; 2 views |
27 |
24 |
$305.75 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
185 |
177 |
$272.89 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
57 |
55 |
$259.75 |
| 85610 |
|
52 |
49 |
$224.37 |
| 87186 |
|
32 |
31 |
$210.80 |
| 83605 |
|
19 |
15 |
$168.15 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
384 |
265 |
$140.98 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
155 |
151 |
$95.29 |
| 85730 |
|
37 |
36 |
$93.05 |
| J7050 |
Infusion, normal saline solution, 250 cc |
128 |
88 |
$58.65 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,004 |
834 |
$34.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
58 |
55 |
$22.05 |
| 71045 |
Radiologic examination, chest; single view |
14 |
13 |
$19.86 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
661 |
623 |
$10.38 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
14 |
12 |
$3.08 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
120 |
54 |
$0.98 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
13 |
13 |
$0.00 |
| 96376 |
|
222 |
203 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
716 |
345 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13 |
12 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
179 |
175 |
$0.00 |
| 82962 |
|
34 |
29 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
37 |
37 |
$0.00 |
| 94760 |
|
117 |
45 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
61 |
57 |
$0.00 |
| 94761 |
|
16 |
14 |
$0.00 |